5.19 USD
-0.09 (-1.7%)
5.045 USD
-0.15 (-2.79%)
ChartMill assigns a Buy % Consensus number of 86% to PYXS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.94. This target is 33.64% above the current price.
PYXS was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about PYXS.
In the previous month the buy percentage consensus was at a similar level.
PYXS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-11-04 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-04 | Guggenheim | Initiate | Buy |
| 2025-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-21 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-11-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Stephens & Co. | Initiate | Overweight |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Stifel | Initiate | Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-09 | BTIG | Initiate | Buy |
| 2024-01-23 | Leerink Partners | Initiate | Outperform |
| 2023-11-30 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-05 | RBC Capital | Initiate | Outperform |
| 2023-07-31 | EF Hutton | Initiate | Buy |
| 2023-03-23 | Credit Suisse | Reiterate | Outperform |
| 2021-11-02 | Credit Suisse | Initiate | Outperform |
| 2021-11-02 | B of A Securities | Initiate | Neutral |
| 2021-11-02 | Jefferies | Initiate | Buy |
PYXIS ONCOLOGY INC / PYXS FAQ
What is the price target for PYXS stock?
14 analysts have analysed PYXS and the average price target is 6.94 USD. This implies a price increase of 33.64% is expected in the next year compared to the current price of 5.19.
What is the consensus rating for PYXS stock?
The consensus rating for PYXIS ONCOLOGY INC (PYXS) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for PYXS stock?
The number of analysts covering PYXIS ONCOLOGY INC (PYXS) is 14.